GL1X · GenesisL1 explorer

MolNFT v1 · #131300 · protein

Ligand binding to farnesoid-X-receptor

5Q13 · Bile acid receptor: “Ligand binding to farnesoid-X-receptor”. X-ray diffraction, 1 ligand (9MD), 5 pockets (best druggability 0.85). MolNFT v1 #131300 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5Q13
Type
protein
Length
483 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bile acid receptor; Coactivator peptide src-1 HD3
UniProt
Q96RI1, A8K1V4
Ligands
9MD
Pockets
5 · best druggability 0.85

Structure

x-ray diffraction · 4 distinct chains · 72% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABile acid receptorprotein23272% helix, 0% strandQ96RI1
BCoactivator peptide src-1 HD3protein1070% helix, 0% strandA8K1V4
CBile acid receptorprotein23072% helix, 0% strandQ96RI1
DCoactivator peptide src-1 HD3protein1173% helix, 0% strandA8K1V4

Ligands and binding sites

  • 9MD · (2S)-2-[6-chloro-2-(4-chlorophenyl)-5-fluoro-1H-benzimidazol-1-yl]-N-cyclohexyl-2-[(2S)-oxan-2-yl]acetamide · ligand · 2 copies · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13300.850.94389MD
24400.840.91459MD
31410.480.7820empty
41440.430.7523empty
5730.330.7512empty

Interfaces

3 interfaces between chains.

  • C–D · 620 Ų buried · 9 hydrogen bonds · protein-protein
  • A–B · 554 Ų buried · 10 hydrogen bonds · protein-protein
  • A–C · 464 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 5Q13 · Ligand binding to FARNESOID-X-RECEPTOR · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.